HK1222884A1 - 用於治疗心力衰竭和增加心脏功能的不能产生环腺苷酸的腺苷酸环化酶和组合物和方法 - Google Patents
用於治疗心力衰竭和增加心脏功能的不能产生环腺苷酸的腺苷酸环化酶和组合物和方法 Download PDFInfo
- Publication number
- HK1222884A1 HK1222884A1 HK16111093.5A HK16111093A HK1222884A1 HK 1222884 A1 HK1222884 A1 HK 1222884A1 HK 16111093 A HK16111093 A HK 16111093A HK 1222884 A1 HK1222884 A1 HK 1222884A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- ac6mut
- cardiac
- nucleic acid
- cell
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y406/00—Phosphorus-oxygen lyases (4.6)
- C12Y406/01—Phosphorus-oxygen lyases (4.6.1)
- C12Y406/01001—Aodenylate cyclase (4.6.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Virology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361832759P | 2013-06-07 | 2013-06-07 | |
| US61/832,759 | 2013-06-07 | ||
| PCT/US2014/040948 WO2014197624A1 (en) | 2013-06-07 | 2014-06-04 | Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1222884A1 true HK1222884A1 (zh) | 2017-07-14 |
Family
ID=52008569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16111093.5A HK1222884A1 (zh) | 2013-06-07 | 2014-06-04 | 用於治疗心力衰竭和增加心脏功能的不能产生环腺苷酸的腺苷酸环化酶和组合物和方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11040091B2 (https=) |
| EP (1) | EP3004343B1 (https=) |
| JP (1) | JP6571069B2 (https=) |
| KR (1) | KR20160032090A (https=) |
| CN (1) | CN105452458A (https=) |
| AU (1) | AU2014274902B2 (https=) |
| BR (1) | BR112015030355A8 (https=) |
| CA (1) | CA2914029A1 (https=) |
| DK (1) | DK3004343T3 (https=) |
| HK (1) | HK1222884A1 (https=) |
| IL (1) | IL242885B (https=) |
| RU (1) | RU2015155831A (https=) |
| WO (1) | WO2014197624A1 (https=) |
| ZA (1) | ZA201508942B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016164920A1 (en) * | 2015-04-09 | 2016-10-13 | Cornell University | Gene therapy to prevent reactions to allergens |
| EP3530278A4 (en) * | 2016-10-24 | 2019-10-30 | Gwangju Institute of Science and Technology | COMPOSITION WITH PROTEIN-PHOSPHATASE-1-INHIBITING PEPTIDE FOR THE TREATMENT OF VASCULAR DISEASES |
| WO2018090036A1 (en) * | 2016-11-14 | 2018-05-17 | Renova Therapeutics, Inc. | Method of protection for cardiac tissue |
| US11760987B2 (en) | 2017-09-07 | 2023-09-19 | The Regents Of The University Of California | Compositions and methods for the treatment or prevention of heart failure |
| EP3689363A4 (en) * | 2017-09-29 | 2021-05-19 | BethphaGen Inc. | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIAC ARRHYTHMIA |
| US20210260215A1 (en) * | 2018-06-08 | 2021-08-26 | University Of Florida Research Foundation, Incorporated | Aav cardiac gene therapy for cardiomyopathy |
| CN109010799B (zh) * | 2018-07-09 | 2021-07-06 | 沣潮医药科技（上海）有限公司 | RyR2蛋白或RyR2重组蛋白在制备抗心力衰竭药物中的用途 |
| CN109191052B (zh) * | 2018-10-22 | 2020-09-25 | 山东大学 | 一种多车型车辆路径优化方法、服务器及系统 |
| CN116234917A (zh) | 2020-07-27 | 2023-06-06 | 安杰瑞姆生物科学公司 | Dna分子组合物及其制备方法和使用方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2395839A1 (en) | 1999-12-27 | 2001-07-05 | The Regents Of The University Of California | Gene therapy for congestive heart failure |
-
2014
- 2014-06-04 CN CN201480044190.5A patent/CN105452458A/zh active Pending
- 2014-06-04 EP EP14808138.3A patent/EP3004343B1/en active Active
- 2014-06-04 US US14/893,905 patent/US11040091B2/en active Active
- 2014-06-04 WO PCT/US2014/040948 patent/WO2014197624A1/en not_active Ceased
- 2014-06-04 HK HK16111093.5A patent/HK1222884A1/zh unknown
- 2014-06-04 AU AU2014274902A patent/AU2014274902B2/en active Active
- 2014-06-04 DK DK14808138.3T patent/DK3004343T3/en active
- 2014-06-04 BR BR112015030355A patent/BR112015030355A8/pt not_active Application Discontinuation
- 2014-06-04 JP JP2016517971A patent/JP6571069B2/ja active Active
- 2014-06-04 KR KR1020167000315A patent/KR20160032090A/ko not_active Ceased
- 2014-06-04 RU RU2015155831A patent/RU2015155831A/ru not_active Application Discontinuation
- 2014-06-04 CA CA2914029A patent/CA2914029A1/en not_active Abandoned
-
2015
- 2015-12-02 IL IL242885A patent/IL242885B/en active IP Right Grant
- 2015-12-08 ZA ZA2015/08942A patent/ZA201508942B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014274902B2 (en) | 2020-06-04 |
| IL242885B (en) | 2019-12-31 |
| JP2016521708A (ja) | 2016-07-25 |
| EP3004343B1 (en) | 2018-10-10 |
| CA2914029A1 (en) | 2014-12-11 |
| BR112015030355A8 (pt) | 2019-12-24 |
| RU2015155831A3 (https=) | 2018-03-28 |
| AU2014274902A1 (en) | 2015-12-24 |
| JP6571069B2 (ja) | 2019-09-04 |
| WO2014197624A1 (en) | 2014-12-11 |
| KR20160032090A (ko) | 2016-03-23 |
| DK3004343T3 (en) | 2019-02-04 |
| US11040091B2 (en) | 2021-06-22 |
| US20160101164A1 (en) | 2016-04-14 |
| ZA201508942B (en) | 2019-05-29 |
| CN105452458A (zh) | 2016-03-30 |
| BR112015030355A2 (pt) | 2017-07-25 |
| EP3004343A1 (en) | 2016-04-13 |
| RU2015155831A (ru) | 2017-07-14 |
| EP3004343A4 (en) | 2017-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6571069B2 (ja) | 環状アデノシン一リン酸−インコンピテントアデニリルシクラーゼならびに心不全を処置するおよび心機能を増大させるための組成物および方法 | |
| CN108310396B (zh) | 用于心血管疾病和其它病况的旁分泌基因的全身性递送和受调节的表达 | |
| JP2021045136A (ja) | 最適化されたミニ−ジストロフィン遺伝子および発現カセットおよびそれらの使用 | |
| US20160166651A1 (en) | Systemic delivery of virus vectors encoding urocortin-2 and related genes to treat diabetes-related cardiac dysfunctions and congestive heart failure | |
| US11760987B2 (en) | Compositions and methods for the treatment or prevention of heart failure | |
| WO2015153357A1 (en) | Compositions and methods for improving cardiac function | |
| HK1257863A1 (en) | Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions | |
| HK1203845B (en) | Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions |